Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 387

1.

Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study.

Bernasconi C, Pelkonen O, Andersson TB, Strickland J, Wilk-Zasadna I, Asturiol D, Cole T, Liska R, Worth A, Müller-Vieira U, Richert L, Chesne C, Coecke S.

Toxicol In Vitro. 2019 May 31;60:212-228. doi: 10.1016/j.tiv.2019.05.019. [Epub ahead of print]

2.

Underestimated Effect of a Polymer Matrix on the Light Emission of Single CsPbBr3 Nanocrystals.

Rainò G, Landuyt A, Krieg F, Bernasconi C, Ochsenbein ST, Dirin DN, Bodnarchuk MI, Kovalenko MV.

Nano Lett. 2019 Jun 12;19(6):3648-3653. doi: 10.1021/acs.nanolett.9b00689. Epub 2019 May 28.

PMID:
31117751
3.

Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study.

Freitas R, Dos Santos B, Altamura C, Bernasconi C, Corral R, Evans J, Malla A, Krebs MO, Nordstroem AL, Zink M, Haro JM, Elkis H.

Psychiatry Res. 2019 Jun;276:210-217. doi: 10.1016/j.psychres.2019.05.002. Epub 2019 May 8.

PMID:
31108345
4.

Unraveling the Radiative Pathways of Hot Carriers upon Intense Photoexcitation of Lead Halide Perovskite Nanocrystals.

Papagiorgis P, Manoli A, Michael S, Bernasconi C, Bodnarchuk MI, Kovalenko MV, Othonos A, Itskos G.

ACS Nano. 2019 May 28;13(5):5799-5809. doi: 10.1021/acsnano.9b01398. Epub 2019 May 13.

PMID:
31070887
5.

Stimulation of the globus pallidus internus in the treatment of Parkinson's disease: Long-term results of a monocentric cohort.

Lachenmayer ML, Bettschen C, Bernasconi C, Petermann K, Debove I, Muellner J, Michelis JP, Burgunder JM, Krauss JK, Oertel MF, Pollo C, Kaelin-Lang A, Schüpbach M.

Parkinsonism Relat Disord. 2019 Mar 16. pii: S1353-8020(19)30102-6. doi: 10.1016/j.parkreldis.2019.03.009. [Epub ahead of print]

PMID:
30935828
6.

Follow-up Computed Tomography after Evacuation of Chronic Subdural Hematoma.

Schucht P, Fischer U, Fung C, Bernasconi C, Fichtner J, Vulcu S, Schöni D, Nowacki A, Wanderer S, Eisenring C, Krähenbühl AK, Mattle HP, Arnold M, Söll N, Tochtermann L, Z'Graggen W, Jünger ST, Gralla J, Mordasini P, Dahlweid FM, Raabe A, Beck J.

N Engl J Med. 2019 Mar 21;380(12):1186-1187. doi: 10.1056/NEJMc1812507. No abstract available.

PMID:
30893542
7.

Robust Hydrophobic and Hydrophilic Polymer Fibers Sensitized by Inorganic and Hybrid Lead Halide Perovskite Nanocrystal Emitters.

Papagiorgis PG, Manoli A, Alexiou A, Karacosta P, Karagiorgis X, Papaparaskeva G, Bernasconi C, Bodnarchuk MI, Kovalenko MV, Krasia-Christoforou T, Itskos G.

Front Chem. 2019 Feb 26;7:87. doi: 10.3389/fchem.2019.00087. eCollection 2019.

8.

Rationalizing and Controlling the Surface Structure and Electronic Passivation of Cesium Lead Halide Nanocrystals.

Bodnarchuk MI, Boehme SC, Ten Brinck S, Bernasconi C, Shynkarenko Y, Krieg F, Widmer R, Aeschlimann B, Günther D, Kovalenko MV, Infante I.

ACS Energy Lett. 2019 Jan 11;4(1):63-74. doi: 10.1021/acsenergylett.8b01669. Epub 2018 Nov 27.

9.

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL.

Mult Scler. 2018 Dec 19:1352458518814117. doi: 10.1177/1352458518814117. [Epub ahead of print]

PMID:
30566027
10.

ACE-inhibitors: a preventive measure for bone flap resorption after autologous cranioplasty?

Schütz A, Murek M, Stieglitz LH, Bernasconi C, Vulcu S, Beck J, Raabe A, Schucht P.

J Neurosurg. 2018 Nov 1:1-8. doi: 10.3171/2018.6.JNS172605. [Epub ahead of print]

PMID:
30497161
11.

Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Classen G, Classen C, Bernasconi C, Brandt C, Gold R, Chan A, Hoepner R.

J Neurovirol. 2019 Feb;25(1):133-136. doi: 10.1007/s13365-018-0689-2. Epub 2018 Nov 9.

PMID:
30414049
12.

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.

Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L.

Ann Neurol. 2018 Oct;84(4):527-536. doi: 10.1002/ana.25313.

13.

Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance.

Gouliarmou V, Lostia AM, Coecke S, Bernasconi C, Bessems J, Dorne JL, Ferguson S, Testai E, Remy UG, Brian Houston J, Monshouwer M, Nong A, Pelkonen O, Morath S, Wetmore BA, Worth A, Zanelli U, Zorzoli MC, Whelan M.

Toxicol In Vitro. 2018 Dec;53:233-244. doi: 10.1016/j.tiv.2018.08.004. Epub 2018 Aug 9.

PMID:
30099088
14.

Health-related quality of life associated with different symptoms in women and in men who suffer from schizophrenia.

Domenech C, Bernasconi C, Moneta MV, Nordstroem AL, Cristobal-Narvaez P, Vorstenbosch E, Cobo J, Ochoa S, Haro JM.

Arch Womens Ment Health. 2019 Jun;22(3):357-365. doi: 10.1007/s00737-018-0896-0. Epub 2018 Aug 7.

PMID:
30088146
15.

Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.

Haro JM, Altamura C, Corral R, Elkis H, Evans J, Krebs MO, Zink M, Malla A, Méndez JI, Bernasconi C, Lalonde J, Nordstroem AL.

Psychiatry Res. 2018 Sep;267:56-62. doi: 10.1016/j.psychres.2018.04.005. Epub 2018 Apr 10.

PMID:
29883861
16.

Exploration of Near-Infrared-Emissive Colloidal Multinary Lead Halide Perovskite Nanocrystals Using an Automated Microfluidic Platform.

Lignos I, Morad V, Shynkarenko Y, Bernasconi C, Maceiczyk RM, Protesescu L, Bertolotti F, Kumar S, Ochsenbein ST, Masciocchi N, Guagliardi A, Shih CJ, Bodnarchuk MI, deMello AJ, Kovalenko MV.

ACS Nano. 2018 Jun 26;12(6):5504-5517. doi: 10.1021/acsnano.8b01122. Epub 2018 May 22.

17.

Feasibility, safety, and outcome of recanalization treatment in childhood stroke.

Bigi S, Dulcey A, Gralla J, Bernasconi C, Melliger A, Datta AN, Arnold M, Kaesmacher J, Fluss J, Hackenberg A, Maier O, Weber J, Poloni C, Fischer U, Steinlin M.

Ann Neurol. 2018 Jun;83(6):1125-1132. doi: 10.1002/ana.25242.

18.

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.

Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M, Bernasconi C, Pethö-Schramm A.

Rheumatology (Oxford). 2018 Jun 1;57(6):1129. doi: 10.1093/rheumatology/key116. No abstract available.

19.

Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics.

Hakkola J, Bernasconi C, Coecke S, Richert L, Andersson TB, Pelkonen O.

Basic Clin Pharmacol Toxicol. 2018 Sep;123 Suppl 5:42-50. doi: 10.1111/bcpt.13004. Epub 2018 Apr 29. Review.

PMID:
29527807
20.

Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time.

Domenech C, Altamura C, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Krebs MO, Nordstroem AL, Zink M, Haro JM.

Soc Psychiatry Psychiatr Epidemiol. 2018 Mar;53(3):239-248. doi: 10.1007/s00127-018-1483-4. Epub 2018 Jan 16.

PMID:
29340780
21.

Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries.

Choy E, Caporali R, Xavier R, Fautrel B, Sanmarti R, Bao M, Bernasconi C, Pethö-Schramm A.

Rheumatology (Oxford). 2018 Mar 1;57(3):499-507. doi: 10.1093/rheumatology/kex443. Erratum in: Rheumatology (Oxford). 2018 Jun 1;57(6):1129.

22.

Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis: A Pooled Analysis of 2 Registries.

Bellwald S, Weber R, Dobrocky T, Nordmeyer H, Jung S, Hadisurya J, Mordasini P, Mono ML, Stracke CP, Sarikaya H, Bernasconi C, Berger K, Arnold M, Chapot R, Gralla J, Fischer U.

Stroke. 2017 Dec;48(12):3282-3288. doi: 10.1161/STROKEAHA.117.018459. Epub 2017 Nov 7.

PMID:
29114095
23.

3D-constructive interference into steady state (3D-CISS) labyrinth signal alteration in patients with vestibular schwannoma.

Wagner F, Herrmann E, Wiest R, Raabe A, Bernasconi C, Caversaccio M, Vibert D.

Auris Nasus Larynx. 2018 Aug;45(4):702-710. doi: 10.1016/j.anl.2017.09.011. Epub 2017 Sep 22.

PMID:
28947096
24.

Behavioral Changes in Patients with Multiple Sclerosis.

Heldner MR, Kaufmann-Ezra S, Gutbrod K, Bernasconi C, Bigi S, Blatter V, Mattle HP, Müri RM, Verma RK, Kamm CP.

Front Neurol. 2017 Aug 28;8:437. doi: 10.3389/fneur.2017.00437. eCollection 2017.

25.

Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.

Choy EH, Bernasconi C, Aassi M, Molina JF, Epis OM.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1484-1494. doi: 10.1002/acr.23303. Epub 2017 Sep 6.

26.

Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.

Haraoui B, Casado G, Czirják L, Taylor A, Bernasconi C, Reiss W, Caporali R.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):899-906. Epub 2017 Apr 28.

PMID:
28516886
27.

Burden of illness of people with persistent symptoms of schizophrenia: A multinational cross-sectional study.

Nordstroem AL, Talbot D, Bernasconi C, Berardo CG, Lalonde J.

Int J Soc Psychiatry. 2017 Mar;63(2):139-150. doi: 10.1177/0020764016688040. Epub 2017 Jan 29.

PMID:
28134026
28.

Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37.

Forssmann WG, Tillmann HC, Hock D, Forssmann K, Bernasconi C, Forssmann U, Richter R, Hocher B, Pfützner A.

Kidney Blood Press Res. 2016;41(5):507-518. Epub 2016 Aug 4.

29.

Practical Aspects of Designing and Conducting Validation Studies Involving Multi-study Trials.

Coecke S, Bernasconi C, Bowe G, Bostroem AC, Burton J, Cole T, Fortaner S, Gouliarmou V, Gray A, Griesinger C, Louhimies S, Gyves EM, Joossens E, Prinz MJ, Milcamps A, Parissis N, Wilk-Zasadna I, Barroso J, Desprez B, Langezaal I, Liska R, Morath S, Reina V, Zorzoli C, Zuang V.

Adv Exp Med Biol. 2016;856:133-163. Review.

PMID:
27671721
30.

GC-MS and GC-MS/MS measurement of ibuprofen in 10-μL aliquots of human plasma and mice serum using [α-methylo-2H3]ibuprofen after ethyl acetate extraction and pentafluorobenzyl bromide derivatization: Discovery of a collision energy-dependent H/D isotope effect and pharmacokinetic application to inhaled ibuprofen-arginine in mice.

Tsikas D, Kayacelebi AA, Hanff E, Mitschke A, Beckmann B, Tillmann HC, Gutzki FM, Müller M, Bernasconi C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 1;1043:158-166. doi: 10.1016/j.jchromb.2016.06.014. Epub 2016 Jun 9.

PMID:
27343144
31.

Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.

Bijlsma JWJ, Welsing PMJ, Woodworth TG, Middelink LM, Pethö-Schramm A, Bernasconi C, Borm MEA, Wortel CH, Ter Borg EJ, Jahangier ZN, van der Laan WH, Bruyn GAW, Baudoin P, Wijngaarden S, Vos PAJM, Bos R, Starmans MJF, Griep EN, Griep-Wentink JRM, Allaart CF, Heurkens AHM, Teitsma XM, Tekstra J, Marijnissen ACA, Lafeber FPJ, Jacobs JWG.

Lancet. 2016 Jul 23;388(10042):343-355. doi: 10.1016/S0140-6736(16)30363-4. Epub 2016 Jun 7.

PMID:
27287832
32.

Virtual car accidents of epilepsy patients, interictal epileptic activity, and medication.

Nirkko AC, Bernasconi C, von Allmen A, Liechti C, Mathis J, Krestel H.

Epilepsia. 2016 May;57(5):832-40. doi: 10.1111/epi.13361. Epub 2016 Apr 4.

33.

Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis.

Broeg-Morvay A, Mordasini P, Bernasconi C, Bühlmann M, Pult F, Arnold M, Schroth G, Jung S, Mattle HP, Gralla J, Fischer U.

Stroke. 2016 Apr;47(4):1037-44. doi: 10.1161/STROKEAHA.115.011134. Epub 2016 Feb 23.

PMID:
26906917
34.

Methotrexate Adherence Questionnaire: a New Tool to Assess Adherence in Patients Treated with Methotrexate.

Dias-Barbosa C, Guillemin I, Aassi M, Bernasconi C, Brethous M, Reiss W, Arnould B, Curtis JR.

Value Health. 2015 Nov;18(7):A714-5. doi: 10.1016/j.jval.2015.09.2697. Epub 2015 Oct 20. No abstract available.

35.

Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.

Haro JM, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs MO, Zink M, Bernasconi C, Lalonde J, Nordstroem AL.

Schizophr Res. 2015 Dec;169(1-3):234-240. doi: 10.1016/j.schres.2015.09.001. Epub 2015 Oct 1.

PMID:
26431792
36.

Risk Stratification for Rejection and Infection after Kidney Transplantation.

Cippà PE, Schiesser M, Ekberg H, van Gelder T, Mueller NJ, Cao CA, Fehr T, Bernasconi C.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2213-20. doi: 10.2215/CJN.01790215. Epub 2015 Oct 1.

37.

Management of spontaneous intracranial hypotension - Transorbital ultrasound as discriminator.

Fichtner J, Ulrich CT, Fung C, Knüppel C, Veitweber M, Jilch A, Schucht P, Ertl M, Schömig B, Gralla J, Z'Graggen WJ, Bernasconi C, Mattle HP, Schlachetzki F, Raabe A, Beck J.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):650-5. doi: 10.1136/jnnp-2015-310853. Epub 2015 Aug 18.

38.

Dynamic changes of intramural hematoma in patients with acute spontaneous internal carotid artery dissection.

Heldner MR, Nedelcheva M, Yan X, Slotboom J, Mathier E, Hulliger J, Verma RK, Sturzenegger M, Jung S, Bernasconi C, Arnold M, Wiest R, Fischer U.

Int J Stroke. 2015 Aug;10(6):887-92. doi: 10.1111/ijs.12553. Epub 2015 Jun 29.

PMID:
26121371
39.

Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial.

Dougados M, Huizinga TW, Choy EH, Bingham CO 3rd, Aassi M, Bernasconi C.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1762-6. doi: 10.1002/acr.22633.

40.

Erratum to: Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.

Bykerk VP, Östör AJ, Alvaro-Gracia J, Pavelka K, Ivorra JA, Graninger W, Bensen W, Nurmohamed MT, Krause A, Bernasconi C, Aassi M, Sibilia J.

Clin Rheumatol. 2015 Jul;34(7):1321. doi: 10.1007/s10067-015-2932-z. No abstract available.

41.

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.

Bykerk VP, Östör AJ, Alvaro-Gracia J, Pavelka K, Román Ivorra JA, Graninger W, Bensen W, Nurmohamed MT, Krause A, Bernasconi C, Aassi M, Sibilia J.

Clin Rheumatol. 2015 Mar;34(3):563-71. doi: 10.1007/s10067-014-2857-y. Epub 2015 Jan 22. Erratum in: Clin Rheumatol. 2015 Jul;34(7):1321.

42.

Biotransformation in vitro: An essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data.

Wilk-Zasadna I, Bernasconi C, Pelkonen O, Coecke S.

Toxicology. 2015 Jun 5;332:8-19. doi: 10.1016/j.tox.2014.10.006. Epub 2014 Oct 16. Review.

43.

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data.

Knoll GA, Kokolo MB, Mallick R, Beck A, Buenaventura CD, Ducharme R, Barsoum R, Bernasconi C, Blydt-Hansen TD, Ekberg H, Felipe CR, Firth J, Gallon L, Gelens M, Glotz D, Gossmann J, Guba M, Morsy AA, Salgo R, Scheuermann EH, Tedesco-Silva H, Vitko S, Watson C, Fergusson DA.

BMJ. 2014 Nov 24;349:g6679. doi: 10.1136/bmj.g6679. Review. Erratum in: BMJ. 2014;349:g7543.

44.

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.

Peterfy C, Emery P, Tak PP, Østergaard M, DiCarlo J, Otsa K, Navarro Sarabia F, Pavelka K, Bagnard MA, Gylvin LH, Bernasconi C, Gabriele A.

Ann Rheum Dis. 2016 Jan;75(1):170-7. doi: 10.1136/annrheumdis-2014-206015. Epub 2014 Oct 29.

45.

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.

Huizinga TW, Conaghan PG, Martin-Mola E, Schett G, Amital H, Xavier RM, Troum O, Aassi M, Bernasconi C, Dougados M.

Ann Rheum Dis. 2015 Jan;74(1):35-43. doi: 10.1136/annrheumdis-2014-205752. Epub 2014 Aug 28.

46.

The optimal MMF dose in tacrolimus treated patients.

van Gelder T, Bouamar R, Shuker N, Hesselink D, Weimar W, Kaplan B, Bernasconi C.

Am J Transplant. 2014 May;14(5):1221. doi: 10.1111/ajt.12682. Epub 2014 Mar 17. No abstract available.

47.

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.

Dougados M, Kissel K, Conaghan PG, Mola EM, Schett G, Gerli R, Hansen MS, Amital H, Xavier RM, Troum O, Bernasconi C, Huizinga TW.

Ann Rheum Dis. 2014 May;73(5):803-9. doi: 10.1136/annrheumdis-2013-204761. Epub 2014 Jan 28.

48.

Tritrichomonas foetus: prevalence study in naturally mating bulls in Switzerland.

Bernasconi Ch, Bodmer M, Doherr MG, Janett F, Thomann A, Spycher C, Iten C, Hentrich B, Gottstein B, Müller N, Frey CF.

Vet Parasitol. 2014 Mar 1;200(3-4):289-94. doi: 10.1016/j.vetpar.2013.12.029. Epub 2014 Jan 8.

PMID:
24447668
49.

Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis.

Isaacs JD, Harari O, Kobold U, Lee JS, Bernasconi C.

Arthritis Res Ther. 2013;15(6):R204.

50.

PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.

Bessems JG, Loizou G, Krishnan K, Clewell HJ 3rd, Bernasconi C, Bois F, Coecke S, Collnot EM, Diembeck W, Farcal LR, Geraets L, Gundert-Remy U, Kramer N, Küsters G, Leite SB, Pelkonen OR, Schröder K, Testai E, Wilk-Zasadna I, Zaldívar-Comenges JM.

Regul Toxicol Pharmacol. 2014 Feb;68(1):119-39. doi: 10.1016/j.yrtph.2013.11.008. Epub 2013 Nov 26.

PMID:
24287156

Supplemental Content

Loading ...
Support Center